Avior Wealth Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-33	Closed	-$7.76K	–	792
2024 Q4	$7.76K	Buy	33 +28	+560%	+$7.36K	﹤0.01%	1705
2024 Q3	$1.38K	Sell	5 -4	-44%	-$1.04K	﹤0.01%	2036
2024 Q2	$2.19K	Hold	9	–	–	﹤0.01%	1927
2024 Q1	$1.34K	Buy	+9	New	+$1.5K	﹤0.01%	2341
2020 Q2	–	Sell	-1,420	Closed	-$154K	–	888
2020 Q1	$154K	Sell	1,420 -1,070	-43%	-$124K	0.03%	378
2019 Q4	$286K	Sell	2,490 -390	-14%	-$38.9K	0.05%	331
2019 Q3	$231K	Sell	2,880 -1,560	-35%	-$123K	0.04%	346
2019 Q2	$322K	Buy	4,440 +1,380	+45%	+$106K	0.06%	280
2019 Q1	$285K	Buy	3,060 +1,330	+77%	+$111K	0.06%	284
2018 Q4	$126K	Buy	1,730 +650	+60%	+$50K	0.03%	401
2018 Q3	$95K	Sell	1,080 -310	-22%	-$31.2K	0.02%	440
2018 Q2	$137K	Buy	+1,390	New	+$138K	0.03%	412